Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia
Clinical trial NCT05665075 · UNKNOWN
Trial details
- NCT number
- NCT05665075
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-24
- Primary completion
- 2023-12-24
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.